CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Operating Expenses [Abstract]
Research and development (including related party amounts of $29 and $475,respectively)	$ 10,707	$ 5,530
General and administrative	3,186	1,098
Total operating expenses	13,893	6,628
Operating loss	(13,893)	(6,628)
Other income (expense)
Interest income	9
Other income (expense), net	58	(8)
Total other income (expense), net	67	(8)
Net loss before income tax	(13,826)	(6,636)
Income tax expense	(4,420)
Net loss	$ (18,246)	$ (6,636)
Net loss per share, basic and diluted	$ (18.94)	$ (7.42)
Weighted-average common shares outstanding, basic and diluted	963,588	894,060